US502504A
(en)
|
|
1893-08-01 |
|
Hermann thoms |
DE487014C
(de)
|
1927-10-23 |
1929-12-09 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von Harnstoffderivaten
|
US1792156A
(en)
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
DE511468C
(de)
|
1928-01-18 |
1930-10-30 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
|
DE523437C
(de)
|
1928-12-25 |
1931-05-05 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
US2288422A
(en)
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
US2973386A
(en)
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
US2502504A
(en)
*
|
1946-10-18 |
1950-04-04 |
John L Botner |
Hogshead
|
DE920245C
(de)
|
1950-04-29 |
1954-11-18 |
Variapat Ag |
Verfahren zur Herstellung von aromatischen, farblosen, wasserloeslichen Trifluormethyl- und Sulfosaeuregruppen enthaltenden unsymmetrischen Harnstoffen bzw. Thioharnstoffen
|
US2683082A
(en)
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
US2722544A
(en)
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
US2781330A
(en)
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
BE527017A
(es)
|
1953-03-06 |
|
|
|
US2745874A
(en)
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
NL193403A
(es)
|
1953-12-22 |
1924-02-17 |
|
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
US2877268A
(en)
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
US2960488A
(en)
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
NL254871A
(es)
|
1959-08-14 |
|
|
|
NL277504A
(es)
|
1961-04-21 |
|
|
|
CH479557A
(de)
|
1961-09-11 |
1969-10-15 |
Wander Ag Dr A |
Verfahren zur Herstellung neuer mehrbasischer Verbindungen
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
US3284433A
(en)
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
FR90420E
(es)
|
1965-06-09 |
1968-02-21 |
|
|
US3424760A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424762A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
US3424761A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
SE370866B
(es)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
DE1768244A1
(de)
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
US3646059A
(en)
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
US3668222A
(en)
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
US3860645A
(en)
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
US4116671A
(en)
|
1973-07-27 |
1978-09-26 |
Shionogi & Co., Ltd. |
3-Isoxazolylcarbamate derivatives
|
US4212981A
(en)
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
JPS5031039A
(es)
|
1973-07-27 |
1975-03-27 |
|
|
US4001256A
(en)
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
US4009847A
(en)
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
US4111683A
(en)
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
JPS5840946B2
(ja)
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
N−ベンゾイル−n′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
US4071524A
(en)
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
US4183854A
(en)
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
US4042372A
(en)
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
JPS5562066A
(en)
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
FI800559A
(fi)
|
1979-03-14 |
1980-09-15 |
Hoffmann La Roche |
Urinaemnederivat
|
JPS55124763A
(en)
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
US4468380A
(en)
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
WO1981002156A1
(en)
|
1980-01-25 |
1981-08-06 |
Reanal Finomvegyszergyar |
Process for the preparation of n-aryl-n'-(mono-or disubstiuted)-urea derivatives
|
EP0040179B1
(de)
|
1980-05-14 |
1984-08-29 |
Ciba-Geigy Ag |
Phenylbenzoylharnstoffe
|
EP0057797B1
(en)
|
1981-02-03 |
1986-06-25 |
Imperial Chemical Industries Plc |
Process for the extraction of metal values and novel metal extractants
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4511571A
(en)
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
DE3211851A1
(de)
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
JPS58203957A
(ja)
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
AU1862083A
(en)
|
1982-09-02 |
1984-03-08 |
Duphar International Research B.V. |
Tumor growth inhibitors
|
CA1254212A
(en)
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
US4499097A
(en)
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
CH663353A5
(de)
|
1984-03-28 |
1987-12-15 |
Joaquin Amat Larraz |
Mittel gegen krebs.
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
JPS6193163A
(ja)
|
1984-10-12 |
1986-05-12 |
Ishihara Sangyo Kaisha Ltd |
N−ベンゾイル−n′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
DE3541631A1
(de)
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
EP0255297B1
(en)
|
1986-07-31 |
1993-04-21 |
Beecham Group Plc |
Azabicyclic compounds, process for their preparation, and their pharmaceutical use
|
EP0262560A3
(en)
|
1986-09-29 |
1989-07-05 |
Ishihara Sangyo Kaisha, Ltd. |
Benzoyl urea compound
|
US4835180A
(en)
|
1986-10-02 |
1989-05-30 |
Sterling Drug Inc. |
N-(ω-cyanoalkyl)aminophenols and use as inhibitors of lipoxygenase activity
|
NZ221964A
(en)
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
EP0264904A3
(en)
|
1986-10-23 |
1988-08-17 |
Ishihara Sangyo Kaisha, Ltd. |
Pharmaceutical compositions containing benzoyl urea derivatives
|
DE3636190A1
(de)
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
EP0314615B1
(de)
|
1987-10-16 |
1995-04-26 |
Ciba-Geigy Ag |
Schädlingsbekämpfungsmittel
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
WO1990002112A1
(en)
|
1988-08-23 |
1990-03-08 |
The Nutrasweet Company |
Substituted aryl ureas as high potency sweeteners
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
JPH02196719A
(ja)
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
JP3002204B2
(ja)
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
US4973675A
(en)
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
DK40890D0
(da)
|
1990-02-16 |
1990-02-16 |
Ferrosan As |
Substituerede urinstofforbindelser, deres fremstilling og anvendelse
|
NZ238624A
(en)
|
1990-06-19 |
1994-08-26 |
Meiji Seika Co |
Pyridine derivatives, compositions, preparations and use thereof
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
HU214333B
(hu)
|
1991-01-21 |
1998-03-02 |
Shionogi Seiyaku Kabushiki Kaisha |
Eljárás benzilidén-karbamoil-2-pirrolidon, -4-tiazolidinon, -4-oxazolidinon, -3-izotiazolidinon- és -3-izoxazolidinon-analógok és az ezeket tartalmazó gyógyszerkészítmények előállítására
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5185438A
(en)
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
US5100883A
(en)
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
FI921595A
(fi)
|
1991-04-17 |
1992-10-18 |
American Home Prod |
Rapamycinkarbamater
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
US5118677A
(en)
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
US5185358A
(en)
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
AU2552492A
(en)
|
1991-08-23 |
1993-03-16 |
United States of America as represented by The Secretary Department of Health and Human Services, The |
Raf protein kinase therapeutics
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
US5254582A
(en)
|
1992-02-05 |
1993-10-19 |
Eli Lilly And Company |
Antitumor compositions and methods
|
EP0630373A1
(en)
|
1992-03-12 |
1994-12-28 |
Smithkline Beecham Plc |
Indole derivatives as 5ht1c antagonists
|
US6001860A
(en)
|
1992-05-28 |
1999-12-14 |
Pfizer Inc. |
N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT)
|
US5312820A
(en)
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
CN2146707Y
(zh)
|
1992-09-08 |
1993-11-17 |
华东冶金学院 |
高炉软水冷却系统检漏装置
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
TW272942B
(es)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US6514745B1
(en)
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
US5378725A
(en)
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
NZ264063A
(en)
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
US5504103A
(en)
|
1993-08-25 |
1996-04-02 |
Eli Lilly And Company |
Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
DK0724588T3
(da)
|
1993-09-17 |
2000-05-15 |
Smithkline Beecham Corp |
Lægemiddelbindende protein
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
US6361773B1
(en)
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
CA2133815A1
(en)
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
US5596001A
(en)
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
DE69433501T2
(de)
|
1993-11-08 |
2004-11-04 |
Smithkline Beecham Corp. |
Oxazole zur behandlung von zytokinvermittelten erkrankungen
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
CH686211A5
(de)
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US6811779B2
(en)
*
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
WO1995033458A1
(en)
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
US5447957A
(en)
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
US5480906A
(en)
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
US5597719A
(en)
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
EP0784612A1
(en)
|
1994-10-04 |
1997-07-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives and their use as acat-inhibitors
|
PT708085E
(pt)
|
1994-10-19 |
2002-11-29 |
Novartis Ag |
Eteres antivirais de isosteros de substrato de aspartato protease
|
CA2161376C
(en)
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
PT788564E
(pt)
|
1994-10-28 |
2001-11-30 |
Novozymes As |
Processo para o apresto quimico de polimeros insoluveis
|
TW313568B
(es)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
FR2729567B1
(fr)
*
|
1995-01-20 |
1997-06-13 |
Oreal |
Composition de teinture d'oxydation des fibres keratiniques et procede de teinture mettant en oeuvre cette composition
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
EP0809492A4
(en)
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
DE19512639A1
(de)
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
MX9604165A
(es)
|
1995-09-18 |
1997-10-31 |
Sankyo Co |
Nuevos derivados de urea que tienen actividad inhibidora de acil-coa: colesterol acil transferasa; su preparacion y su uso terapeutico y profilactico.
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
JP4009681B2
(ja)
|
1995-11-07 |
2007-11-21 |
キリンファーマ株式会社 |
血小板由来成長因子受容体自己リン酸化を阻害するキノリン誘導体ならびにキナゾリン誘導体およびそれらを含有する薬学的組成物
|
AU1173997A
(en)
|
1995-12-28 |
1997-07-28 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Process for producing pyridinecarboxamides or thiocarboxamides
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6211373B1
(en)
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
ATE189814T1
(de)
|
1996-04-15 |
2000-03-15 |
Takeda Chemical Industries Ltd |
Hydroxypyridin-derivate, ihre herstellung und ihre pharmazeutische verwendung
|
HUP0004421A3
(en)
|
1996-04-23 |
2002-10-28 |
Vertex Pharmaceuticals Inc Cam |
Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
JPH09301858A
(ja)
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
DE69716424T2
(de)
|
1996-05-24 |
2003-02-20 |
Neurosearch A/S, Ballerup |
Saure gruppen enthaltende phenylderivate, ihre herstellung und ihre verwendung als chloridkanalblocker
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
KR20000022274A
(ko)
|
1996-06-27 |
2000-04-25 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
Il-8 수용체 길항제
|
EP0932405A4
(en)
|
1996-06-27 |
2001-10-17 |
Smithkline Beckman Corp |
IL-8 RECEPTOR ANTAGONISTS
|
JP2000513359A
(ja)
|
1996-06-27 |
2000-10-10 |
スミスクライン・ビーチャム・コーポレイション |
Il―8受容体拮抗薬
|
HUP9903922A3
(en)
|
1996-06-27 |
2001-12-28 |
Smithkline Beecham Corp |
Il-8 receptor antagonists
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
US5808080A
(en)
|
1996-09-05 |
1998-09-15 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
WO1998017207A1
(en)
|
1996-10-21 |
1998-04-30 |
Synthes Ag Chur |
Surgical prosthetic device
|
WO1998017267A1
(en)
|
1996-10-23 |
1998-04-30 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
DE69739734D1
(de)
|
1996-11-15 |
2010-02-25 |
Cytokine Pharmasciences Inc |
Guanylhydrazone die nützlich sind zur behandlung von mit t-zellen verbundenen krankheiten
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
AU4966497A
(en)
|
1996-11-18 |
1998-06-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
|
FR2755967B1
(fr)
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
KR20000070368A
(ko)
|
1997-01-23 |
2000-11-25 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
인터루킨-8 수용체 길항제
|
US5929250A
(en)
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
DE19706061A1
(de)
|
1997-02-07 |
1998-08-13 |
Schering Ag |
Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
|
JP2001512445A
(ja)
|
1997-02-12 |
2001-08-21 |
スミスクライン・ビーチャム・コーポレイション |
Il−8レセプターアンタゴニスト
|
CN1254335A
(zh)
|
1997-04-04 |
2000-05-24 |
辉瑞产品公司 |
烟酰胺衍生物
|
EP0973735B1
(en)
|
1997-04-10 |
2003-01-29 |
PHARMACIA & UPJOHN COMPANY |
Polyaromatic antiviral compositions
|
WO1998049150A1
(en)
|
1997-04-25 |
1998-11-05 |
Takeda Chemical Industries, Ltd. |
Triazine derivatives, their production and agrochemical composition
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
EP1019394A1
(en)
|
1997-05-22 |
2000-07-19 |
G.D. Searle & Co. |
PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
|
JP2002502379A
(ja)
|
1997-05-22 |
2002-01-22 |
ジー.ディー.サール アンド カンパニー |
p38キナーゼインヒビターとしての3(5)−ヘテロアリール置換ピラゾール
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
US6187799B1
(en)
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
ES2153337T3
(es)
|
1997-05-23 |
2008-11-01 |
Bayer Pharmaceuticals Corporation |
Inhibidores de la quinasa raf.
|
US6344476B1
(en)
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
ES2151467T3
(es)
|
1997-05-23 |
2005-03-01 |
Bayer Corporation |
Arilureas para el tratamiento de enfermedades inflamatorias o inmunomoduladoras.
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
US5985592A
(en)
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
EP1023066A4
(en)
|
1997-06-13 |
2001-05-23 |
Smithkline Beecham Corp |
NEW PYRAZOLE AND PYRAZOLINE SUBSTITUTED COMPOUND
|
EP1020444A4
(en)
|
1997-06-27 |
2001-04-11 |
Kureha Chemical Ind Co Ltd |
6-PHENOXYPICOLINIC ACID, ALKYLIDENEHYDRAZIDE DERIVATIVES, THEIR PRODUCTION PROCESS, AND HERBICIDE
|
US6093742A
(en)
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
US6525065B1
(en)
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
WO1999020617A1
(en)
|
1997-10-21 |
1999-04-29 |
Active Biotech Ab |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
AU748041B2
(en)
|
1997-10-31 |
2002-05-30 |
Aventis Pharma Limited |
Substituted anilides
|
JP2001521934A
(ja)
|
1997-11-03 |
2001-11-13 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症薬としての芳香族ヘテロ環式化合物
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
AU1407899A
(en)
|
1997-12-01 |
1999-06-16 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
US6174901B1
(en)
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
IL136738A0
(en)
|
1997-12-22 |
2001-06-14 |
Bayer Ag |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
US20120046290A1
(en)
|
1997-12-22 |
2012-02-23 |
Jacques Dumas |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
DK1043995T3
(da)
|
1997-12-22 |
2007-03-05 |
Bayer Pharmaceuticals Corp |
Inhibering af p38 kinaseaktivitet ved anvendelse af aryl- og heteroaryl-substituerede, heterocykliske urinstoffer
|
DE69830513T2
(de)
|
1997-12-22 |
2006-03-16 |
Bayer Pharmaceuticals Corp., West Haven |
HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
SK286564B6
(sk)
|
1997-12-22 |
2009-01-07 |
Bayer Corporation |
Substituované arylmočoviny ako inhibítory rafkinázy a farmaceutický prípravok s ich obsahom
|
CN1117081C
(zh)
|
1997-12-22 |
2003-08-06 |
拜尔有限公司 |
用芳基取代或杂芳基取代的杂环脲抑制raf激酶
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
ATE300299T1
(de)
|
1997-12-22 |
2005-08-15 |
Bayer Pharmaceuticals Corp |
Inhibierung der raf-kinase durch substituierte heterocyclische harnstoffverbindungen
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
WO1999033458A1
(fr)
|
1997-12-25 |
1999-07-08 |
Daiichi Pharmaceutical Co., Ltd. |
Composition medicinale pour administration percutanee
|
WO1999037604A2
(en)
|
1998-01-21 |
1999-07-29 |
Zymogenetics, Inc. |
Dialkyl ureas as calcitonin mimetics
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
US6878526B1
(en)
|
1998-02-18 |
2005-04-12 |
Theryte Limited |
Treating cancer
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
US6413773B1
(en)
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
JP2002526482A
(ja)
|
1998-09-18 |
2002-08-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
p38のインヒビター
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
HUP0104302A3
(en)
|
1998-11-06 |
2002-11-28 |
Abbott Gmbh & Co Kg |
Inhibition of the formation of vascular hyperpermeability
|
IL143328A0
(en)
|
1998-11-25 |
2002-04-21 |
Genetica Inc |
Methods and reagents for increasing proliferative capacity and preventing replicative senescence
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
WO2000035455A1
(en)
|
1998-12-15 |
2000-06-22 |
Telik, Inc. |
Heteroaryl-aryl ureas as igf-1 receptor antagonists
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
CA2348923A1
(en)
|
1998-12-18 |
2000-06-22 |
Dean A. Wacker |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
WO2000039116A1
(fr)
|
1998-12-25 |
2000-07-06 |
Teikoku Hormone Mfg. Co., Ltd. |
Derives d'aminopyrazole
|
US7351834B1
(en)
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US7928239B2
(en)
*
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
IL144144A0
(en)
|
1999-01-13 |
2002-05-23 |
Bayer Ag |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
TWI284642B
(en)
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
TR200102090T2
(tr)
|
1999-01-22 |
2002-01-21 |
Kirin Beer Kabushiki Kaisha |
Kinolin türevleri ve kinazolin türevleri.
|
DE60013250T2
(de)
|
1999-02-12 |
2005-09-08 |
Smithkline Beecham P.L.C., Brentford |
Phenylharnstoff- und Phenylthioharnstoffderivate als Orexinrezeptorantagonisten
|
JP2002537397A
(ja)
|
1999-02-22 |
2002-11-05 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症剤としての多環ヘテロ環式誘導体
|
CN1511830A
(zh)
|
1999-03-12 |
2004-07-14 |
���ָ��.Ӣ��ķҩ�﹫˾ |
作为消炎剂的化合物
|
JP2002539206A
(ja)
|
1999-03-12 |
2002-11-19 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症剤としての芳香族複素環化合物
|
SK13332001A3
(sk)
|
1999-03-19 |
2002-02-05 |
Vertex Pharmaceuticals Incorporated |
Inhibítory IMPDH enzýmu a ich použitie
|
EP2266960B1
(en)
|
1999-03-26 |
2014-01-22 |
Euro-Celtique S.A. |
Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
ES2218156T3
(es)
|
1999-05-05 |
2004-11-16 |
Aventis Pharma Limited |
Ureas y su uso como moduladores de la adhesion celular.
|
KR20020000223A
(ko)
|
1999-05-14 |
2002-01-05 |
존 비. 랜디스 |
표피성장인자 수용체 길항제를 사용한 인간 난치성 종양의치료 방법
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
ATE312823T1
(de)
|
1999-07-09 |
2005-12-15 |
Boehringer Ingelheim Pharma |
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
|
CN1151453C
(zh)
|
1999-07-09 |
2004-05-26 |
酒井康江 |
取样函数波形数据发生装置
|
DE60024631T2
(de)
|
1999-07-26 |
2006-06-14 |
Banyu Pharma Co Ltd |
Biaryl-harnstoff-derivate
|
ATE321751T1
(de)
|
1999-07-28 |
2006-04-15 |
Kirin Brewery |
Harnstoffderivate als ccr-3 rezeptor-inhibitoren
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
MXPA02003742A
(es)
|
1999-10-15 |
2003-10-14 |
Kampen Group Inc Van |
Tratamiento de tumores dermicos, verrugas e infecciones virales usando p. acnes muerto por calor.
|
DE60036726T2
(de)
|
1999-11-16 |
2008-02-07 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Harnstoff derivate als entzündungshemmende mittel
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
MXPA02007632A
(es)
|
2000-02-07 |
2004-08-23 |
Abbott Gmbh & Co Kg |
Derivados de 2-benzotiazolil urea y su uso como inhibidores de proteina cinasa.
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
ES2377119T3
(es)
|
2000-03-02 |
2012-03-22 |
Vegenics Pty Ltd |
Procedimientos para tratar cánceres que expresan el factor de crecimiento endotelial vascular D
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
RU2002130822A
(ru)
|
2000-04-19 |
2004-03-27 |
Фудзисава Фармасьютикал Ко., Лтд. (JP) |
Твердая дисперсия с улучшенной абсорбируемостью
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
WO2002007008A1
(en)
|
2000-04-28 |
2002-01-24 |
Ubink Cornelis Hubertus Johann |
Network procurement system
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
EP1311277A4
(en)
|
2000-07-18 |
2004-08-25 |
Joslin Diabetes Center Inc |
FIBROSIS MODULATION METHOD
|
MXPA02012909A
(es)
|
2000-07-24 |
2004-05-05 |
Boehringer Ingelheim Pharma |
Formulaciones mejoradas de dosis oral de 1-(5-ter-butil -2-p-tiolil2h -pirazol-3 -il)-3-(4-2 (2-morfolin-4-il -etoxi) -naftalen -1-il) -urea.
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
US20020165349A1
(en)
|
2000-08-04 |
2002-11-07 |
Kirsch Wolff M. |
Iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease
|
WO2002014281A1
(en)
|
2000-08-11 |
2002-02-21 |
Vertex Pharmaceuticals Incorporated |
Pyridine derivatives as inhibitors of p38
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
KR20040074096A
(ko)
|
2000-08-17 |
2004-08-21 |
샤단호칭키타사토겐큐쇼 |
신규 슈도에리쓰로마이신 유도체
|
IL154016A0
(en)
|
2000-08-31 |
2003-07-31 |
Pfizer Prod Inc |
Pyrazole derivatives and their use as protein kinase inhibitors
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
NZ525324A
(en)
|
2000-10-20 |
2005-03-24 |
Eisai Co Ltd |
Nitrogenous aromatic ring compounds
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
JP2004513935A
(ja)
|
2000-11-17 |
2004-05-13 |
ノボ ノルディスク アクティーゼルスカブ |
グルカゴンアンタゴニスト/逆アゴニスト
|
AU2002217870A1
(en)
|
2000-11-27 |
2002-06-03 |
Eric A. Brill |
System, method, and program for sorting objects
|
GEP20053652B
(en)
|
2000-11-28 |
2005-11-10 |
Pfizer Prod Inc |
Salts of A Isothiazole-4-Carboxamide and their Use as Anti-Hyperproliferation Agents
|
JP2004517080A
(ja)
|
2000-11-29 |
2004-06-10 |
グラクソ グループ リミテッド |
Tie−2および/またはvegfr−2の阻害剤として有用なベンゾイミダゾール誘導体
|
EP1363925B8
(en)
|
2000-12-21 |
2007-04-25 |
Glaxo Group Limited |
Macrolide antibiotics
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
CA2435829A1
(en)
|
2001-01-25 |
2002-08-01 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
WO2002066019A2
(en)
|
2001-02-19 |
2002-08-29 |
Novartis Ag |
Cancer treatment
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
EP1366021B1
(en)
|
2001-03-07 |
2007-07-11 |
Telik, Inc. |
Substituted diarylureas as stimulators for fas-mediated apoptosis
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
ES2280517T3
(es)
|
2001-03-23 |
2007-09-16 |
Bayer Pharmaceuticals Corporation |
Inhibidor de rho-cinasa.
|
JP2005504727A
(ja)
|
2001-04-13 |
2005-02-17 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症薬として有用なウレア化合物
|
JP2005507367A
(ja)
|
2001-04-13 |
2005-03-17 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
1,4−二置換ベンゾ縮合化合物
|
DE60218445T2
(de)
|
2001-04-20 |
2007-11-29 |
Bayer Pharmaceuticals Corp., West Haven |
Inhibierung der raf-kinase durch chinolin-, isochinolin- oder pyridin-harnstoffe
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
WO2002088090A2
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Pyrazole derived kinase inhibitors
|
EP1392661A1
(en)
|
2001-05-16 |
2004-03-03 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
CA2453147A1
(en)
|
2001-07-11 |
2003-01-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediated diseases
|
US7371736B2
(en)
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
SE0103838D0
(sv)
|
2001-11-16 |
2001-11-16 |
Astrazeneca Ab |
Pharmaceutical formulation & product
|
DK2305255T3
(da)
|
2001-12-03 |
2012-12-10 |
Bayer Healthcare Llc |
Arylurinstofforbindelser i kombination med andre cytostatiske eller cytotoksiske midler til behandling af humane cancere
|
EP1578346A4
(en)
*
|
2001-12-04 |
2007-11-28 |
Onyx Pharma Inc |
INHIBITORS OF THE RAF-MEK-ERK PATHWAY TO TREAT CANCER
|
ES1050706Y
(es)
|
2001-12-12 |
2002-08-16 |
Climastar Thermostone S L |
Convector electrico mejorado
|
JP4643909B2
(ja)
|
2001-12-21 |
2011-03-02 |
ザ ウェルカム トラスト リミテッド |
遺伝子
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
AU2002356323A1
(en)
|
2001-12-24 |
2003-07-30 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
US20080108672A1
(en)
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
WO2003059373A2
(en)
|
2002-01-16 |
2003-07-24 |
Ramot At Tel Aviv University Ltd. |
Compositions and their use for enhancing and inhibiting fertilization
|
DE60318177T2
(de)
|
2002-01-23 |
2008-10-09 |
Bayer Pharmaceuticals Corp., West Haven |
Rho-kinase inhibitoren
|
MXPA04007191A
(es)
|
2002-01-23 |
2005-03-31 |
Bayer Pharmaceuticals Corp |
Derivados de pirimidina como inhibidores de rho-quinasa.
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
US7928277B1
(en)
|
2002-02-11 |
2011-04-19 |
Cox Jr Henry Wilmore |
Method for reducing contamination
|
PT1580188E
(pt)
|
2002-02-11 |
2012-01-25 |
Bayer Healthcare Llc |
Aril-ureias como inibidores de cinases
|
US20030216396A1
(en)
|
2002-02-11 |
2003-11-20 |
Bayer Corporation |
Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
|
WO2003068228A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Aryl ureas with angiogenesis inhibiting activity
|
US7645878B2
(en)
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
AU2003250197B2
(en)
|
2002-08-27 |
2009-11-12 |
Merck Patent Gmbh |
Glycinamide derivatives as raf-kinase inhibitors
|
CA2495284A1
(en)
|
2002-09-05 |
2004-03-18 |
Neurosearch A/S |
Diarylurea derivatives and their use as chloride channel blockers
|
CA2503445C
(en)
|
2002-10-24 |
2012-07-31 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Methylene urea derivatives as raf-kinase inhibitors
|
AU2003291356A1
(en)
|
2002-11-06 |
2004-06-03 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for treating cancer using proteasome inhibitors
|
AU2003283399B2
(en)
|
2002-11-15 |
2007-04-19 |
Novartis Ag |
Drug delivery system
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
GB0317227D0
(en)
|
2003-07-23 |
2003-08-27 |
Pfizer Ltd |
Treatment of male sexual dysfunction
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
WO2004078746A2
(en)
*
|
2003-02-28 |
2004-09-16 |
Bayer Pharmaceuticals Corporation |
2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
|
WO2004078128A2
(en)
|
2003-02-28 |
2004-09-16 |
Bayer Pharmaceuticals Corporation |
Substituted pyridine derivatives useful in the treatment of cancer and other disorders
|
CA2516931C
(en)
|
2003-02-28 |
2014-09-09 |
Bayer Pharmaceuticals Corporation |
Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
PL377124A1
(pl)
|
2003-03-24 |
2006-01-23 |
Merck Patent Gmbh |
Pochodne oksamidu użyteczne jako inhibitory kinazy raf
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
EP1636585B2
(en)
|
2003-05-20 |
2012-06-13 |
Bayer HealthCare LLC |
Diaryl ureas with kinase inhibiting activity
|
BRPI0410913A
(pt)
|
2003-06-05 |
2006-06-27 |
Warner Lambert Co |
benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
GB2403151A
(en)
|
2003-06-27 |
2004-12-29 |
Intermark Medical Innovations |
A device for rectal lavage
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
CA2531485C
(en)
|
2003-07-07 |
2013-03-26 |
Merck Patent Gmbh |
Malonamide derivatives
|
PT1646634E
(pt)
|
2003-07-08 |
2009-02-16 |
Novartis Ag |
Utilização de rapamicina e derivados de rapamicina para o tratamento de perda óssea
|
WO2005004863A1
(en)
|
2003-07-11 |
2005-01-20 |
Merck Patent Gmbh |
Benzimidazole carboxamides as raf kinase inhibitors
|
US7691886B2
(en)
|
2003-07-11 |
2010-04-06 |
Merck Patent Gmbh |
Benzimidazole derivatives as raf kinase inhibitors
|
WO2005016252A2
(en)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Phosphorus-containing macrocycles
|
US20060234931A1
(en)
|
2003-07-17 |
2006-10-19 |
Biggs William H Iii |
Treatment of diseases with kinase inhibitors
|
MY142799A
(en)
|
2003-07-23 |
2010-12-31 |
Bayer Healthcare Llc |
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
GB0317229D0
(en)
|
2003-07-23 |
2003-08-27 |
Pfizer Ltd |
Improved process
|
AR045134A1
(es)
|
2003-07-29 |
2005-10-19 |
Smithkline Beecham Plc |
Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
KR20060097000A
(ko)
|
2003-09-23 |
2006-09-13 |
노파르티스 아게 |
화학요법제와 vegf 수용체 저해제의 배합물
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
WO2005040100A1
(en)
|
2003-10-15 |
2005-05-06 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene and urea derivatives
|
CA2542653A1
(en)
|
2003-10-16 |
2005-04-28 |
Chiron Corporation |
Substituted benzazoles and use thereof as inhibitors of raf kinase
|
AU2004281154A1
(en)
|
2003-10-16 |
2005-04-28 |
Novartis Vaccines And Diagnostics, Inc. |
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of Raf kinase for treatment of cancer
|
DE10349587A1
(de)
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
US20050165074A1
(en)
|
2003-11-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Amide derivatives as C-KIT modulators
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
CN1889958A
(zh)
|
2003-12-09 |
2007-01-03 |
美国政府健康及人类服务部 |
抑制免疫应答或治疗增生性疾病的方法
|
EP1692110A1
(en)
|
2003-12-10 |
2006-08-23 |
MERCK PATENT GmbH |
Diacylhydrazine derivatives
|
KR20060132882A
(ko)
|
2004-01-30 |
2006-12-22 |
메르크 파텐트 게엠베하 |
비스아릴우레아 유도체
|
CA2560269A1
(en)
|
2004-03-19 |
2005-09-29 |
The Penn State Research Foundation |
Combinatorial methods and compositions for treatment of melanoma
|
EP2295426A1
(en)
|
2004-04-30 |
2011-03-16 |
Bayer HealthCare, LLC |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
WO2006026501A1
(en)
|
2004-08-27 |
2006-03-09 |
Bayer Pharmaceuticals Corporation |
New pharmaceutical compositions for the treatment of cancer
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
JP5334414B2
(ja)
|
2004-09-06 |
2013-11-06 |
バイエル インテレクチュアル プロパティー ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規のピラゾロピリミジン
|
DK1797037T3
(en)
|
2004-09-29 |
2015-03-30 |
Bayer Healthcare Llc |
PROCESS FOR THE PREPARATION OF 4- {4 - [({[4-chloro-3- (trifluoromethyl) phenyl] AMINO} CARBONYL) AMINO] PHENYOXY} N-methylpyridine-2-carboxamide
|
BRPI0515946A
(pt)
|
2004-09-29 |
2008-08-12 |
Bayer Healthcare Ag |
sal de tosilato, sua preparação e uso, bem como composição farmacêutica compreendendo o mesmo
|
ES2465469T3
(es)
|
2005-01-14 |
2014-06-05 |
Gilead Connecticut, Inc. |
Diaril ureas 1,3-sustituidas como moduladores de la actividad quinasa
|
ATE482693T1
(de)
|
2005-03-07 |
2010-10-15 |
Bayer Schering Pharma Ag |
Pharmazeutische zusammensetzung mit einem omega- carboxyaryl-substituierten diphenylharnstoff zur behandlung von krebs
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
JP2008542214A
(ja)
|
2005-05-27 |
2008-11-27 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
疾患を処置するためのジアリールウレア化合物およびpi3、aktキナーゼまたはmtor阻害剤(ラパマイシン)を含む組合せ治療
|
JP2008545670A
(ja)
|
2005-05-27 |
2008-12-18 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
疾患を処置するためのジアリールウレア類を含む組合せ治療
|
WO2007015947A2
(en)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
PL1928872T3
(pl)
|
2005-09-21 |
2012-08-31 |
4Sc Ag |
Nowe sulfonylopirole jako inhibitory HDAC
|
BRPI0617488A2
(pt)
|
2005-10-21 |
2011-07-26 |
Bayer Healthcare Llc |
mÉtodo para a monitoraÇço do estado de uma doenÇa associada a uma via de vegf-165 ativada por ultra-expressço ou por mutaÇço de proteÍna vegf-165 em um paciente, mÉtodo de seleÇço de terapia para um paciente humano com uma doenÇa e mÉtodo de dignàstico para detectar uma doenÇa associada a uma via de vegf-165 ativada por ultra-expressço ou por mutaÇço de proteÍna vegf-165 em um paciente
|
WO2007053574A2
(en)
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Combinations comprising sorafenib and interferon for the treatment of cancer
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
JP2009513706A
(ja)
|
2005-10-31 |
2009-04-02 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
ソラフェニブを用いた癌の治療
|
RU2008121751A
(ru)
|
2005-11-02 |
2009-12-20 |
БАЙЕР ХЕЛСКЕР ЛЛСи (US) |
Способы прогнозирования и предсказания рака и мониторинг терапии раковых заболеваний
|
CA2628849A1
(en)
|
2005-11-10 |
2007-05-18 |
Bayer Healthcare Ag |
Diaryl urea for treating pulmonary hypertension
|
BRPI0618524A2
(pt)
|
2005-11-10 |
2011-09-06 |
Bayer Schering Pharma Ag |
uso de diaril ureias para o tratamento de hipertensão pulmonar, bem como combinação e composição compreendendo as referidas diaril ureias e uso da combinação
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
JP2009515553A
(ja)
|
2005-11-14 |
2009-04-16 |
バイエル ヘルスケア エルエルシー |
癌の予知および予後と、癌治療のモニタリング
|
CA2629863A1
(en)
|
2005-11-14 |
2007-05-24 |
Scott Wilhelm |
Use of sorafenib for the treatment of cancers with acquired resistance to kit inhibitors
|
US20110195110A1
(en)
|
2005-12-01 |
2011-08-11 |
Roger Smith |
Urea compounds useful in the treatment of cancer
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
US20100129321A1
(en)
|
2005-12-15 |
2010-05-27 |
Bayer Healthcare Llc |
Diaryl urea for treating virus infections
|
EP1962829A1
(en)
|
2005-12-15 |
2008-09-03 |
Bayer HealthCare AG |
Diaryl ureas for treating virus infections
|
ES2480440T3
(es)
|
2005-12-21 |
2014-07-28 |
Bayer Intellectual Property Gmbh |
Derivados sustituidos de pirimidina útiles en el tratamiento del cáncer y de otros trastornos
|
WO2007087575A2
(en)
|
2006-01-24 |
2007-08-02 |
University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
CA2648106A1
(en)
|
2006-03-31 |
2007-11-01 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
EP2338488A1
(en)
|
2006-05-26 |
2011-06-29 |
Bayer HealthCare, LLC |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
AR062927A1
(es)
|
2006-10-11 |
2008-12-17 |
Bayer Healthcare Ag |
4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
|
CA2667720A1
(en)
|
2006-11-09 |
2008-05-15 |
Abbott Gmbh & Co. Kg. |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
CA2668748A1
(en)
|
2006-11-09 |
2008-05-15 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
|
EP2089363A1
(en)
|
2006-11-14 |
2009-08-19 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]n-methylpyridine-2-carboxamide
|
AU2007336873A1
(en)
|
2006-12-20 |
2008-07-03 |
Bayer Healthcare Llc |
4-{4-[({3-tert-Butyl-1-[3-(hydroxymethyl) phenyl]-1H-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -N-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
|
EP2134677B1
(en)
|
2006-12-20 |
2011-10-12 |
Bayer HealthCare LLC |
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1h-pyrazol-5-yl}carbamoyl)-amino]-3-chlorophenoxy}-n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
|
CA2675979A1
(en)
|
2007-01-19 |
2008-07-24 |
Bayer Healthcare Llc |
Treatment of cancers having resistance to chemotherapeutic agents
|
US8680124B2
(en)
|
2007-01-19 |
2014-03-25 |
Bayer Healthcare Llc |
Treatment of cancers with acquired resistance to kit inhibitors
|
WO2008156024A1
(ja)
|
2007-06-21 |
2008-12-24 |
Sharp Kabushiki Kaisha |
光検出装置、及びそれを備えた表示装置
|
JP5076072B2
(ja)
|
2008-03-24 |
2012-11-21 |
矢崎総業株式会社 |
圧着端子、及びこの圧着端子を用いた圧着構造
|
EP2296641A1
(en)
|
2008-06-25 |
2011-03-23 |
Bayer Schering Pharma Aktiengesellschaft |
Diaryl urea for treating heart failure
|
JP5439494B2
(ja)
|
2008-10-21 |
2014-03-12 |
バイエル ヘルスケア エルエルシー |
肝細胞癌と関連するシグネチャ遺伝子の同定
|
JP5077375B2
(ja)
|
2010-02-26 |
2012-11-21 |
井関農機株式会社 |
コンバイン
|